Alnylam Pharmaceuticals Inc

Latest articles

6d
Boston Globe
Alnylam poised to roll out first-of-its-kind RNA therapy, with a lot riding on the drugclinical trial showed that the drug works — and that it’s safe. And now the bio
Boston Globe / Posted 6 days ago
clinical trial showed that the drug works — and that it’s safe. And now the biotech company behind it, Cambridge-based Alnylam Pharmaceuticals Inc., is poised to bring this first-of-its-kind therapy to market. The news has thrilled both... Read more
26d
Boston Globe
Alnylam’s rare-disease drug shines in trial; stock soars 51%The age of RNA interference drugs has arrived. Alnylam Pharmaceuticals Inc. an
Boston Globe / Posted 26 days ago
The age of RNA interference drugs has arrived. Alnylam Pharmaceuticals Inc. announced positive results Wednesday from a closely watched phase 3 clinical trial of patisiran, the Cambridge biotech company’s experimental treatment for a rare nerve... Read more
26d
FOX Business
Here's Why Arbutus Biopharma Corp. Stock Soared TodayWhat happened Shares of Arbutus Biopharma Corp.(NASDAQ: ABUS) rode some mighty
FOX Business / Posted 26 days ago
What happened Shares of Arbutus Biopharma Corp.(NASDAQ: ABUS) rode some mighty coattails today. This morning, Alnylam Pharmaceuticals, Inc.(NASDAQ: ALNY) announced highly positive data for a candidate that employs delivery technology it licensed... Read more
26d
FOX Business
Here's Why Arbutus Biopharma Corp. Stock Soared TodayReading Below Shares of Arbutus Biopharma Corp.(NASDAQ: ABUS) rode some mighty
FOX Business / Posted 26 days ago
Reading Below Shares of Arbutus Biopharma Corp.(NASDAQ: ABUS) rode some mighty coattails today. This morning, Alnylam Pharmaceuticals, Inc.(NASDAQ: ALNY) announced highly positive data for a candidate that employs delivery technology... Read more
26d
FOX Business
What's Next for Alnylam Pharmaceuticals, Inc.?The past 15 years haven't been easy for Alnylam Pharmaceuticals, Inc.(NASDAQ: A
FOX Business / Posted 26 days ago
The past 15 years haven't been easy for Alnylam Pharmaceuticals, Inc.(NASDAQ: ALNY) shareholders. The company's new drug candidates are based on science that earned a Nobel Prize in 2006, but proving a clear clinical benefit that outweighs any safety... Read more
26d
FOX Business
What's Next for Alnylam Pharmaceuticals, Inc.?The past 15 years haven't been easy for Alnylam Pharmaceuticals, Inc.(NASDAQ: A
FOX Business / Posted 26 days ago
The past 15 years haven't been easy for Alnylam Pharmaceuticals, Inc.(NASDAQ: ALNY) shareholders. The company's new drug candidates are based on science that earned a Nobel Prize in 2006, but proving a clear clinical benefit that outweighs any safety... Read more
26d
Market Watch
Alnylam shares surge 40% on drug results that may herald a new type of medicineAlnylam Pharmaceuticals Inc. shares surged nearly 40% in extremely heavy mornin
Market Watch / Posted 26 days ago
Alnylam Pharmaceuticals Inc. shares surged nearly 40% in extremely heavy morning trade Wednesday after the company said its patisiran therapy met its primary efficacy endpoint and all secondary endpoints in a key late-stage clinical... Read more
26d
Newsmax
New Drug Shows Promise Against Rare Gene DisorderAlnylam Pharmaceuticals Inc. said its drug to treat patients suffering from a r
Newsmax / Posted 26 days ago
Alnylam Pharmaceuticals Inc. said its drug to treat patients suffering from a rare genetic disease met the main goal in a late-stage study, moving the company closer to filing a marketing application for the drug in late 2017. The company's shares... Read more
26d
Market Watch
UPDATE: Alnylam shares jump 24% on positive results from late-stage trial of hATTR amyloidosis treatmentSanofi SAN, +0.30% and Alnylam Pharmaceuticals Inc. ALNY, -1.26% on Wednesday r
Market Watch / Posted 26 days ago
Sanofi SAN, +0.30% and Alnylam Pharmaceuticals Inc. ALNY, -1.26% on Wednesday reported positive results in a late-stage trial of a treatment for Hereditary ATTR (hATTR) Amyliodosis patients with polyneuropathy. Alnylam shares jumped 24% after... Read more

In this news